ABACCEL Trademark

Trademark Overview


On Monday, April 11, 2016, a trademark application was filed for ABACCEL with the United States Patent and Trademark Office. The USPTO has given the ABACCEL trademark a serial number of 86970800. The federal status of this trademark filing is REGISTERED as of Tuesday, September 12, 2017. This trademark is owned by AbCheck s.r.o.. The ABACCEL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services and research projects for the preparation of peptide and antibody libraries, and for the identification and characterisation of binding molecules, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisation of peptides or antibodies, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisation of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, or antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely scientific research and analysis in the field of...
abaccel

General Information


Serial Number86970800
Word MarkABACCEL
Filing DateMonday, April 11, 2016
Status700 - REGISTERED
Status DateTuesday, September 12, 2017
Registration Number5283583
Registration DateTuesday, September 12, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2017

Trademark Statements


Goods and ServicesScientific and technological services and research projects for the preparation of peptide and antibody libraries, and for the identification and characterisation of binding molecules, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisation of peptides or antibodies, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects for the preparation, identification and characterisation of recombinant antibodies, single-chain antibodies, diabodies, tandabs, flexibodies, triabodies, tetrabodies, bivalent antibodies, multivalent antibodies, whole immunoglobulins, or antibody fragments, in particular Fab and scFv fragments, and of nucleic acid sequences coding for these molecules, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of natural, engineered and immunized libraries, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to batch-cloning and screening of antibody libraries, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to antibody development strategies, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to the optimization, maturation and humanization of antibody drug candidates, namely scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to multi-factor antibody optimization, namely scientific research and analysis in the field of antibody research and drug design; scientific and technological services and research projects in relation to the optimization of antibody binding affinity, antibody stability, species cross-reactivity, specificity, developability, producibility, and human properties, namely scientific research and analysis in the field of antibody research and antibody optimization; scientific and technological services and research projects in relation to human and nonhuman lead antibody technology, namely scientific research and analysis in the field of antibody research and antibody optimization

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 15, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbCheck s.r.o.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressPlzen 30100
CZ

Party NameAbCheck s.r.o.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPlzen 30100
CZ

Party NameAbCheck s.r.o.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPlzen 30100
CZ

Trademark Events


Event DateEvent Description
Wednesday, March 6, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, September 12, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 12, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, June 27, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 27, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 7, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 4, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 12, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, March 24, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, March 24, 2017FINAL REFUSAL E-MAILED
Friday, March 24, 2017FINAL REFUSAL WRITTEN
Thursday, February 23, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 23, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 16, 2017ASSIGNED TO LIE
Wednesday, February 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 3, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 3, 2016NON-FINAL ACTION E-MAILED
Wednesday, August 3, 2016NON-FINAL ACTION WRITTEN
Friday, July 29, 2016PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, July 29, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, July 26, 2016ASSIGNED TO EXAMINER
Friday, April 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 14, 2016NEW APPLICATION ENTERED